Roux-en-Y Gastric Bypass in Turkey

Roux-en-Y Gastric Bypass (RYGB) has been the gold standard in bariatric surgery for over four decades. It produces greater and more durable weight loss than sleeve gastrectomy and achieves the highest rates of type 2 diabetes remission among all bariatric procedures. Turkey's experienced bariatric teams offer RYGB laparoscopically, combining excellent outcomes with all-inclusive packages that make this transformative surgery financially accessible.

What is Roux-en-Y Gastric Bypass?

RYGB works through both restriction and malabsorption. The surgeon creates a small gastric pouch (approximately 20–30 ml) from the upper stomach and connects it directly to the mid-small intestine (jejunum), bypassing the rest of the stomach, the duodenum, and the upper jejunum. The bypassed segment is reconnected further down to allow digestive enzymes to mix with food. This dual mechanism limits food intake, reduces caloric absorption, alters gut hormones (increasing GLP-1 and PYY), and profoundly improves metabolic parameters. Type 2 diabetes goes into remission in up to 80 % of patients, often within days of surgery — before significant weight loss occurs.

How is it Performed?

RYGB is performed laparoscopically under general anaesthesia through five to six small incisions. The gastric pouch is fashioned with a linear stapler. The Roux limb of jejunum is measured (typically 75–150 cm for weight loss; 150–200 cm for super-obesity or metabolic disease) and anastomosed to the pouch. The biliopancreatic limb is connected to the alimentary limb at a second anastomosis site. The entire procedure takes approximately 90–150 minutes. Intraoperative leak testing with methylene blue or air ensures anastomotic integrity before closure.

Who Needs Gastric Bypass?

RYGB is particularly beneficial for patients with: BMI ≥ 40 (or ≥ 35 with comorbidities); type 2 diabetes who wish to maximise metabolic remission; severe gastro-oesophageal reflux disease (GERD) that contraindicates sleeve gastrectomy; or patients who have experienced inadequate weight loss or weight regain after a prior sleeve gastrectomy.

Recovery & Aftercare

Hospital stay is two to three days. The same staged dietary progression as sleeve gastrectomy applies — liquids advancing to solids over six weeks. Lifelong vitamin supplementation is mandatory: multivitamin, calcium citrate (not carbonate), vitamin D3, vitamin B12 (sublingual or injected), and iron. Blood tests are recommended every three to six months. Most patients return to work in two to three weeks. Expected weight loss is 70–80 % of excess body weight at twelve months, with maintenance of 65–70 % at five years with good dietary adherence. Turkare coordinates ongoing nutritional monitoring and metabolic follow-up.

Risks & Success Rates

RYGB has a 30-day mortality rate of approximately 0.1–0.3 %. Key complications include anastomotic leak (1–2 %), internal hernia (1–3 % long-term), marginal ulcer (1–4 %), dumping syndrome (15–20 %, usually manageable), and nutritional deficiencies if supplementation is inadequate. Despite a slightly higher surgical complexity than sleeve, long-term outcomes for weight maintenance and metabolic improvement make RYGB the preferred choice for many patients.

Why Turkey & Turkare?

Turkish bariatric surgeons who perform RYGB typically have subspecialty training and contribute to international bariatric registries. Laparoscopic RYGB packages in Turkey are all-inclusive and start at $5,500 — compared to $20,000–$35,000 in Western Europe and the United States. Turkare's bariatric coordinators guide patients from initial consultation through the full post-operative period, including nutrition coaching, support group access, and 12-month metabolic monitoring.